Programme

Lecture Theatre 1B
2022-09-03
15:50-17:05
State Key Lab Meeting (1) - Molecular mechanisms of GI cancer
15:50
Genetic and epigenetic alterations in gastric cancer
16:15
Mettl3 as a therapeutic target in colorectal cancer
16:40
Dual function of MEN1 in modulating colon cancer tumor-microenvironment interactions
Lecture Theatre 1B
2022-09-03
17:05-18:20
State Key Lab Meeting (2) - Microbiome/metabolites, gut-liver axis and liver diseases
17:05
Enterically derived HDL restrains liver injury through the portal vein
17:30
Intestine gene regulates NAFLD through gut-liver axis
17:55
Fecal mycobiome in NAFLD
Lecture Theatre 1B
2022-09-04
09:00-10:30
State Key Lab Meeting (3) - Microbiome and host response
09:00
Microbiome in GI cancer
09:30
Genetic stability and individual specificity of the human gut microbiome
10:00
The role of inflammation in the development of Barrett’s esophagus and esophageal adenocarcinoma
Lecture Theatre 1B
2022-09-04
11:00-12:30
State Key Lab Meeting (4) - Microbiome and cancer therapy
11:00
Microbiome and anti-cancer therapy
11:30
Enterococcus and cancer immunotherapy
12:00
Targeting microbiome for cancer prevention/treatment
Lecture Theatre 1A
2022-09-04
14:30-16:00
COVID-19 and the GUT: lessons learnt
14:30
Gut microbiome and vaccine response
15:00
COVID-19 vaccine and immunosuppressants: chicken or egg?
15:30
Balancing your gut microbiome to fight COVID-19: what’s the evidence?
State Key Lab Meeting (1) - Molecular mechanisms of GI cancer
Lecture Theatre 1B
2022-09-03
15:50
15:50
Genetic and epigenetic alterations in gastric cancer
16:15
Mettl3 as a therapeutic target in colorectal cancer
16:40
Dual function of MEN1 in modulating colon cancer tumor-microenvironment interactions
State Key Lab Meeting (2) - Microbiome/metabolites, gut-liver axis and liver diseases
Lecture Theatre 1B
2022-09-03
17:05
17:05
Enterically derived HDL restrains liver injury through the portal vein
17:30
Intestine gene regulates NAFLD through gut-liver axis
17:55
Fecal mycobiome in NAFLD
State Key Lab Meeting (3) - Microbiome and host response
Lecture Theatre 1B
2022-09-04
09:00
09:00
Microbiome in GI cancer
09:30
Genetic stability and individual specificity of the human gut microbiome
10:00
The role of inflammation in the development of Barrett’s esophagus and esophageal adenocarcinoma
State Key Lab Meeting (4) - Microbiome and cancer therapy
Lecture Theatre 1B
2022-09-04
11:00
11:00
Microbiome and anti-cancer therapy
11:30
Enterococcus and cancer immunotherapy
12:00
Targeting microbiome for cancer prevention/treatment
COVID-19 and the GUT: lessons learnt
Lecture Theatre 1A
2022-09-04
14:30
14:30
Gut microbiome and vaccine response
15:00
COVID-19 vaccine and immunosuppressants: chicken or egg?
15:30
Balancing your gut microbiome to fight COVID-19: what’s the evidence?